- Virbac : Déclaration d'actions et de droits de vote 04/2024
- Virbac : Declaration of the number of shares and voting rights
- Virbac : Communiqué de mise à disposition du Rapport Annuel au format ESEF au 31 décembre 2023
- Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)
- VIRBAC: sur la lancée du second semestre 2023, forte croissance du chiffre d’affaires sur le premier trimestre de +10,8% à taux de change constants
- VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates
- Virbac : Déclaration d'actions et de droits de vote 03/2024
- Virbac : Declaration of the number of shares and voting rights 03/2024
- Virbac acquiert Sasaeah, un acteur majeur de la santé animale au Japon
- Virbac acquired Sasaeah, a leading animal health player in Japan
More ▼
Key statistics
As of last trade Virbac SA (0NM7:LSE) traded at 356.50, -5.31% below its 52-week high of 376.50, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 351.75 |
---|---|
High | -- |
Low | -- |
Bid | 352.00 |
Offer | 360.00 |
Previous close | 355.50 |
Average volume | 158.56 |
---|---|
Shares outstanding | 8.46m |
Free float | 4.28m |
P/E (TTM) | 24.79 |
Market cap | 3.01bn EUR |
EPS (TTM) | 14.36 EUR |
Annual div (ADY) | 1.32 EUR |
---|---|
Annual div yield (ADY) | 0.37% |
Div ex-date | Jun 26 2023 |
Div pay-date | Jun 28 2023 |
Data delayed at least 20 minutes, as of May 10 2024 15:11 BST.
More ▼